SCHEMBL5257442

SCHEMBL5257442

Nc1ccccc1NC(=O)Oc1cc(Cl)n[nH]c1=O

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MEN1 O00255 1/20 0.43
▸ KMT2A Q03164 1/20 0.43
▸ HDAC1 Q13547 14/20 0.41
▸ HDAC2 Q92769 8/20 0.41
▸ HDAC3 O15379 7/20 0.41
▸ HDAC8 Q9BY41 5/20 0.41
▸ HDAC6 Q9UBN7 5/20 0.41
▸ HDAC4 P56524 3/20 0.41
▸ HDAC7 Q8WUI4 3/20 0.41
▸ HDAC10 Q969S8 3/20 0.41
▸ HDAC11 Q96DB2 3/20 0.41
▸ HDAC9 Q9UKV0 3/20 0.41
▸ HDAC5 Q9UQL6 3/20 0.41
▸ MAPK1 P28482 1/20 0.38
▸ KDM4E B2RXH2 1/20 0.38
▸ NPC1 O15118 1/20 0.37
▸ RAB9A P51151 1/20 0.37
▸ NPSR1 Q6W5P4 1/20 0.37
▸ ALDH1A1 P00352 1/20 0.37
▸ CYP1A2 P05177 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5258491 0.86 HDAC1 (0.43) MEN1KMT2AHDAC1HDAC2HDAC3
SCHEMBL5256987 0.86 MEN1 (0.42) MEN1KMT2AHDAC1HDAC2HDAC3
SCHEMBL5254960 0.72 KMT2A (0.34) KMT2A
SCHEMBL10424370 0.69 NPC1 (0.57) MEN1KMT2AHDAC1HDAC2HDAC3
SCHEMBL3380554 0.66 HDAC1 (0.58) HDAC1HDAC2HDAC3HDAC8HDAC6
SCHEMBL1393609 0.64 — —
SCHEMBL3071688 0.62 HDAC3 (0.64) HDAC1HDAC2HDAC3HDAC8HDAC6
SCHEMBL31174164 0.62 HDAC3 (0.64) HDAC1HDAC2HDAC3HDAC8HDAC6
SCHEMBL250263 0.62 HDAC3 (0.64) HDAC1HDAC2HDAC3HDAC8HDAC6
SCHEMBL9515806 0.62 NPC1 (0.67) HDAC1HDAC2HDAC3HDAC8HDAC6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1725543-B1 4-BENZIMIDAZOL-2-YL-PYRIDAZINE-3-ONE-DERIVATIVES, PRODUCTION AND USE THEREOF IN MEDICAMENTS SANOFI AVENTIS DEUTSCHLAND (DE) 2007-11-28 — — EP disclosed
EP-1725543-A1 4-BENZIMIDAZOL-2-YL-PYRIDAZINE-3-ONE-DERIVATIVES, PRODUCTION AND USE THEREOF IN MEDICAMENTS Sanofi-Aventis Deutschland GmbH (DE) 2006-11-29 — — EP disclosed
WO-2005085230-A1 4-BENZIMIDAZOL-2-YL-PYRIDAZINE-3-ONE-DERIVATIVES, PRODUCTION AND USE THEREOF IN MEDICAMENTS SANOFI-AVENTIS DEUTSCHLAND GMBH (DE) 2005-09-15 — — WO disclosed
Send feedback